feed,title,long_url,short_url
Benzinga,Calliditas Plans To File For Complete FDA Approval For Rare Kidney Disease Drug After Positive Phase 3 Data,https://benzinga.com/general/biotech/23/03/31321995/calliditas-plans-to-file-for-complete-fda-approval-for-rare-kidney-disease-drug-after-positive-ph,https://da.gd/LRvnG
